Mechanisms Involved in Reprogramming of Lipid Metabolism on Drug Resistance
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Lipid Metabolism".
Deadline for manuscript submissions: closed (1 August 2022) | Viewed by 399
Special Issue Editors
Interests: metabolomics; cancer; cancer metabolism; cancer stem cells; lipid metabolism; drug resistance
Interests: metabolomics; NMR spectroscopy; oncology; lipid metabolism; metabolism
Interests: metabolomics; NMR spectroscopy; oncology; lipid metabolism; metabolism; cachexia; theranostics; early detection
Special Issue Information
Dear Colleagues,
It is now well established that metabolic reprogramming is closely linked to different oncogenic processes. Altered metabolism is crucial to respond to cancer cell requirements during tumor progression. Lipid metabolic reprogramming, in particular, is recognized as a central player in the tumor being involved in the development, survival, progression of cancer. In recent years, accumulating evidence also suggests that dysregulated lipid metabolism could play a role in resistance to anticancer treatments.
In this Special Issue, we would like to focus on the emerging understanding of biochemical and molecular mechanisms underlying lipid metabolic reprogramming induced by anticancer drugs during the development of drug resistance and highlight their significance in the development of new therapeutic strategies.
Dr. Maria Elena Pisanu
Dr. Iorio Egidio
Dr. Marie-France Penet
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lipid metabolism
- drug resistance
- cancer stem cells
- ROS
- miRNA
- exosome
